Based on the Encompass Health Corp stock forecast from 6 analysts, the average analyst target price for Encompass Health Corp is USD 106.14 over the next 12 months. Encompass Health Corp’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Encompass Health Corp is Neutral, which is based on 8 positive signals and 7 negative signals. At the last closing, Encompass Health Corp’s stock price was USD 101.16. Encompass Health Corp’s stock price has changed by +4.53% over the past week, +10.95% over the past month and +40.85% over the last year.
No recent analyst target price found for Encompass Health Corp
No recent average analyst rating found for Encompass Health Corp
Company Overview Encompass Health Corp
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama. Read Less
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treat...Read More
Frequently Asked Questions About Encompass Health Corp (EHC) Stock
Based on ratings from 6 analysts Encompass Health Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 7 buy, sell and hold ratings.
EHC stock's dividend yield is 0.75%.
Our analysis grades EHC stock's dividend yield at F. This means that EHC stock's dividend yield is above 43% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this EHC may be a average dividend stock for its sector.
Based on targets from 6 analysts, the average taret price for EHC is USD 106.14 over the next 12 months. The maximum analyst target price is USD 110 while the minimum anlayst target price is USD 100.
EHC stock's Price/Earning ratio is 21.42.
Our analysis grades EHC stock's Price / Earning ratio at F. This means that EHC stock's Price/Earning ratio is above 76% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this EHC may be a overvalued for its sector.
The last closing price of EHC's stock was USD 101.16.
The most recent market capitalization for EHC is USD 9.17B.
Based on targets from 6 analysts, the average taret price for EHC is projected at USD 106.14 over the next 12 months.
This means that EHC's stock price may go up by +4.93% over the next 12 months.
We can't find any ETFs which contains Encompass Health Corp's stock.
As per our most recent records Encompass Health Corp has 27,481 Employees.
Encompass Health Corp's registered address is 9001 Liberty Parkway, Birmingham, AL, United States, 35242.
You can get more information about it from Encompass Health Corp's website at https://www.encompasshealth.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior Dividend Growth
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Encompass Health Corp (EHC) Stock
Based on ratings from 6 analysts Encompass Health Corp's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Neutral. The stock has 7 buy, sell and hold ratings.
EHC stock's dividend yield is 0.75%.
Our analysis grades EHC stock's dividend yield at F. This means that EHC stock's dividend yield is above 43% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this EHC may be a average dividend stock for its sector.
Based on targets from 6 analysts, the average taret price for EHC is USD 106.14 over the next 12 months. The maximum analyst target price is USD 110 while the minimum anlayst target price is USD 100.
EHC stock's Price/Earning ratio is 21.42.
Our analysis grades EHC stock's Price / Earning ratio at F. This means that EHC stock's Price/Earning ratio is above 76% of the stocks in the Medical Care Facilities sector in the NYE exchange.
Based on this EHC may be a overvalued for its sector.
The last closing price of EHC's stock was USD 101.16.
The most recent market capitalization for EHC is USD 9.17B.
Based on targets from 6 analysts, the average taret price for EHC is projected at USD 106.14 over the next 12 months.
This means that EHC's stock price may go up by +4.93% over the next 12 months.
We can't find any ETFs which contains Encompass Health Corp's stock.
As per our most recent records Encompass Health Corp has 27,481 Employees.
Encompass Health Corp's registered address is 9001 Liberty Parkway, Birmingham, AL, United States, 35242.
You can get more information about it from Encompass Health Corp's website at https://www.encompasshealth.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for EHC !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
